Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000375576 | SCV000336308 | uncertain significance | not provided | 2015-10-09 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001117358 | SCV001275535 | uncertain significance | Nephronophthisis 8 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001117359 | SCV001275536 | uncertain significance | Meckel syndrome, type 5 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001117360 | SCV001275537 | uncertain significance | Joubert syndrome 7 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Labcorp Genetics |
RCV001241000 | SCV001413989 | uncertain significance | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2022-10-18 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 321 of the RPGRIP1L protein (p.Arg321His). This variant is present in population databases (rs183419371, gnomAD 0.2%). This missense change has been observed in individual(s) with Joubert syndrome (PMID: 27434533). ClinVar contains an entry for this variant (Variation ID: 283929). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RPGRIP1L protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002487213 | SCV002794198 | uncertain significance | Joubert syndrome 7; Meckel syndrome, type 5; COACH syndrome 3 | 2024-02-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000375576 | SCV004010486 | uncertain significance | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV004017583 | SCV004848450 | likely benign | not specified | 2020-08-11 | criteria provided, single submitter | clinical testing | The p.Arg321His variant in RPGRIP1L is classified as likely benign due to lack of conservation among species (at least 3 primate species having a His at this position). It has also been identified in 0.14% (29/19946) of East Asian chromosomes by gnomAD (http://gnomad.broadinstitute.org) and computational prediction tools and conservation analyses suggest that it may not impact the protein. It has been reported in 1 compound heterozygous individual with Joubert syndrome; however, this individual also carried 2 variants in TMEM67 (Suzuki 2016 PMID: PMID: 27434533). ACMG/AMP Criteria applied: BP4_Strong, BS1_Supporting. |
Natera, |
RCV001833330 | SCV002085747 | uncertain significance | Familial aplasia of the vermis | 2020-01-13 | no assertion criteria provided | clinical testing | |
Neurology Department of Pediatrics, |
RCV001117360 | SCV003803088 | uncertain significance | Joubert syndrome 7 | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004535307 | SCV004120631 | uncertain significance | RPGRIP1L-related disorder | 2024-01-09 | no assertion criteria provided | clinical testing | The RPGRIP1L c.962G>A variant is predicted to result in the amino acid substitution p.Arg321His. This variant has been reported in the compound heterozygous state in an individual with Joubert syndrome and in the heterozygous state in an individual with adolescent idiopathic scoliosis (Suzuki et al. 2016. PubMed ID: 27434533; Supplementary Table 4, Jiang et al. 2020. PubMed ID: 32381728). This variant is reported in 0.15% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |